<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00945659</url>
  </required_header>
  <id_info>
    <org_study_id>1R01DK080831</org_study_id>
    <secondary_id>1R01DK080831</secondary_id>
    <nct_id>NCT00945659</nct_id>
  </id_info>
  <brief_title>Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control</brief_title>
  <acronym>CGM-Teens</acronym>
  <official_title>Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nemours Children's Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Nemours Children's Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incorporation of continuous glucose sensors (CGS) into management of type 1 diabetes in
      adolescence could improve treatment outcomes. But, behavioral barriers may prevent
      adolescents from enjoying optimal benefits from this new technology. This study will
      randomize adolescents (11 to not yet 17 years old) with type 1 diabetes for at least 2 years
      who are not achieving targeted HbA1c levels (&gt; 7.5%) to continue in standard care (SC), to
      add continuous glucose monitoring (CGM) to their care with appropriate education and medical
      management (CGS) or to add CGM to their care as above but to also receive support and
      assistance from a behavior therapist who will assist the patient and family in optimizing the
      adolescents' therapeutic benefit from CGS (CGS+BT). A variety of outcomes will be measured,
      including blood glucose control, quality of life, and CGS satisfaction and impact. An
      enrollment criterion for this study is that the adolescent must have established consistent
      care for type 1 diabetes at a Nemours Children's Clinic location either in Wilmington, DE,
      Philadelphia, PA, Orlando, FL or Pensacola, FL for at least 12 months prior to enrollment in
      the study. Adolescents treated elsewhere are not eligible to enroll in the study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Management of type 1 diabetes mellitus (T1DM) in adolescents is very difficult and innovative
      approaches are needed to help them achieve better glycemic control and behavioral outcomes.
      Continuous glucose sensors (CGS) have been refined progressively and provide acceptably
      accurate, nearly continuous estimates of glucose levels and trends. This increased quality
      and quantity of glucose data could be an excellent adjunct to conventional self-monitoring of
      blood glucose, permitting more informed diabetes decision-making. CGS could yield medical,
      educational and psychological benefits for adolescents with T1DM, but those with extremely
      variable self-management habits and suboptimal glycemic control may not realize these
      benefits readily. We hypothesize that a targeted, family-focused behavioral intervention
      could optimize benefit from adding CGS to T1DM therapy for youths with glycosylated
      hemoglobin (HbA1c) &gt; 7.5%. A multi-site sample of 150 adolescents with T1DM and HbA1C of 7.5%
      to 10.0% will be randomized to either Standard Care for T1DM (SC), or to augmentation of SC
      with 9 months' use of a CGS device (CGS) or use of a CGS device supplemented with a targeted
      behavior therapy intervention (CGS+BT). Multiple measures of glycemic control, glycemic
      variability and health care use will be obtained during the study and there will be periodic
      assessments of demographic factors, diabetes self-management, family relations and
      psychological adjustment. Three specific aims will be addressed: 1. Evaluate whether CGS+BT
      yields more improvement in glycemic outcomes than CGS or SC; 2. Evaluate whether CGS+BT
      yields more improvement in behavioral outcomes than CGS or SC; and 3. Identify behavioral
      variables that mediate and moderate glycemic benefit from use of the CGS device. The study
      will also compare the cost effectiveness of CGS and CGS+BT relative to SC and evaluate the
      predictive utility of various indices of glycemic variability in youths. We hypothesize that,
      compared with SC and CGS, CGS+BT will yield significantly better biomedical outcomes (HbA1C;
      severe hypoglycemia; glycemic variability; proportion of glucose readings in the normal
      range) and behavioral outcomes (treatment adherence; parent adolescent teamwork;
      diabetes-related family conflict; quality of life; fear of hypoglycemia; and treatment
      satisfaction). After the 9 month randomized trial, all youths will be allowed to use the CGS
      device during an additional 3-month continuation phase. Statistical analyses will be based on
      individual growth modeling techniques. The application capitalizes on the Principal
      Investigator's prior and ongoing funded research on family management of T1DM, including
      trials of family-focused behavioral interventions, intensive therapy regimens, and clinical
      evaluations of continuous glucose sensors. The proposed study will determine whether a
      targeted behavioral intervention improves CGS benefits among adolescents with previously
      inadequate glycemic control. These results could demonstrate that adolescents with previously
      suboptimal diabetic control could realize multiple benefits from CGS use if they are provided
      with a specialized behavioral intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>3 group (Standard Care: Continuous Glucose Monitor; Continuous Glucose Monitor + Behavior Therapy) X 4 time points (0, 3, 6, and 9 months) Repeated measures randomized treatments design.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated Hemoglobin (HbA1c)</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Glycated hemoglobin (HbA1c) expressed as a percentage of hemoglobin molecules bound to glucose.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes Technology Questionnaire-Adolescents</measure>
    <time_frame>Baseline, 3 6, 9 months</time_frame>
    <description>Adolescent's total score on the DTQ-Current items. Range 30-150. Higher scores indicate more favorable satisfaction with and impact of the package of diabetes technology (e.g. pump, meter, CGM, etc.) in use by the patient during the prior 3 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Technology Questionnaire-Parents' Total Scores on DTQ Current Items</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Parents' ratings of impact and satisfaction with the diabetes devices currently in use (e.g. pump, meter, CGM etc.) Score range from 30-150. Higher score signify greater satisfaction and impact.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Glucose Monitoring Communication Questionnaire-Adolescent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Adolescent report of communication with parents about blood glucose monitoring and results. Range 8-24. Higher scores indicate more negative communication about BG results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Glucose Monitoring Communication Questionnaire-Parents</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Parents perspectives of communication with adolescent around blood glucose monitoring and results. Score range 8-24. Higher scores signify more negative communication about BG results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Family Conflict Scale-Adolescent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Adolescent ratings of degree of diabetes-related family conflict. Score range 19-57. Higher scores indicate more frequent family conflict around diabetes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Family Conflict Scale-Parent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Parents' ratings of degree of diabetes-related family conflict. Score range 19-57. Higher scores indicate more family conflict around diabetes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Family Responsibility Questionnaire-Adolescent</measure>
    <time_frame>Baserline, 3, 6, 9 months</time_frame>
    <description>Adolescent's self-ratings of their degree of responsibility for 38 diabetes tasks. Score range 0-76. Lower scores indicate greater adolescent responsibility for diabetes care.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Family Responsibility Questionnaire-Parent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Parent ratings of adolescent's degree of responsibility for 38 diabetes tasks. Score range 0-76. Lower scores indicate great adolescent responsibility for diabetes care tasks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Self Management Profile-Adolescent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Adolescent self-report of diabetes management behaviors. Score range 0-86. Higher scores indicate more meticulous diabetes treatment adherence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Self Management Profile-Parent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Parent report of adolescent's diabetes self-management behaviors. Score range 0-86. Higher scores indicate more meticulous diabetes treatment adherence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia Fear Survey-Adolescent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Adolescent worry and behavior related to apprehension of low BG episodes. Score range 24-72. Higher scores indicate greater fear and avoidance of hypoglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia Fear Survey-Parent</measure>
    <time_frame>Baseline, 3, 6, 9 months</time_frame>
    <description>Parental worry and behavior related to apprehension of low BG events. Score range 24-72. Higher scores indicate greater parental fear and avoidance of hypoglycemia.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">116</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous Glucose Sensor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CGS + Behavior Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Glucose Sensor</intervention_name>
    <description>Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
    <arm_group_label>Continuous Glucose Sensor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Care</intervention_name>
    <description>Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CGS + Behavior Therapy</intervention_name>
    <description>Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
    <arm_group_label>CGS + Behavior Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age of adolescent &gt; 11 years and &lt; 17 years. This age range was chosen because
             families of adolescents often struggle with diabetes management. Youths &gt; 18 years old
             may be likely to leave home during the study.

          2. Diagnosis of type 1 diabetes based on the clinician's best judgment regarding the
             adolescent's proper diagnostic category.

          3. Duration of type 1 diabetes &gt; 2 years or &gt; 1 year with negligible stimulated c-peptide
             level, to exclude those with significant residual pancreatic insulin production.

          4. Treatment of diabetes for the 6 months prior to enrollment must consist of an
             intensified regimen including either daily use of an insulin pump or 3 or more daily
             insulin injections with pre-meal insulin doses calculated using a correction factor
             that considers prevailing blood glucose levels and planned carbohydrate intake.

          5. Adolescent must have established diabetes care at a participating Nemours Children's
             Clinic site as evidenced by at least two diabetes clinic visits within the prior 12
             months.

          6. Most recent HbA1C &gt; 7.5% and &lt; 10.0% or mean HbA1C over the prior 12 months within
             that same range.

          7. Intention to remain in the same region and to maintain diabetes care at the enrolling
             center for 12 months.

          8. Family has working telephone service.

        Exclusion Criteria:

          1. Youth has not used a CGM device with real-time glucose feedback for clinical
             management of diabetes within the prior 6 months. Intermittent or one-time use of
             &quot;blinded&quot; CGM devices for retrospective analysis only is permissible.

          2. Absence of any other medical conditions that, in the opinion of the attending
             endocrinologist, would impede completion of the study protocol.

          3. Youths may not be on daily glucocorticoid medications due to hyperglycemic effects of
             these agents.

          4. Not enrolled in special education for mental retardation, autism or severe behavior
             disorders.

          5. Child not in an inpatient psychiatric unit or day treatment program during the 6
             months prior to enrollment.

          6. Primary diabetes caregiver not diagnosed or in treatment for major depression,
             psychosis, bipolar disorder or substance use disorder within the 6 months prior to
             enrollment; Child not in an inpatient psychiatric unit or day treatment program during
             the 6 months prior to enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim Wysocki, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours Children's Clinic Jacksonville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <results_first_submitted>June 4, 2018</results_first_submitted>
  <results_first_submitted_qc>August 8, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 10, 2018</results_first_posted>
  <last_update_submitted>August 8, 2018</last_update_submitted>
  <last_update_submitted_qc>August 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nemours Children's Clinic</investigator_affiliation>
    <investigator_full_name>Timothy Wysocki</investigator_full_name>
    <investigator_title>Principal Research Scientist and Center Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT00945659/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 26, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT00945659/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Care</title>
          <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
        </group>
        <group group_id="P2">
          <title>Continuous Glucose Sensor</title>
          <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
        </group>
        <group group_id="P3">
          <title>CGS + Behavior Therapy</title>
          <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>3-Months</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6-Months</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>9-Months</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>12-Months</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Care</title>
          <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
        </group>
        <group group_id="B2">
          <title>Continuous Glucose Sensor</title>
          <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
        </group>
        <group group_id="B3">
          <title>CGS + Behavior Therapy</title>
          <description>Patients in this group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="39"/>
            <count group_id="B3" value="35"/>
            <count group_id="B4" value="112"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Adolescent Age in Years</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.61" spread="1.76"/>
                    <measurement group_id="B2" value="13.62" spread="1.82"/>
                    <measurement group_id="B3" value="13.46" spread="1.98"/>
                    <measurement group_id="B4" value="13.56" spread="1.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="98"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="92"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glycated Hemoglobin Level (%)</title>
          <description>Glycated hemoglobin level expressed as percentage of hemoglobin molecules bound to glucose molecules.</description>
          <units>Percentage of hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.84" spread="0.95"/>
                    <measurement group_id="B2" value="9.03" spread="1.07"/>
                    <measurement group_id="B3" value="9.24" spread="0.83"/>
                    <measurement group_id="B4" value="9.03" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Glycated Hemoglobin (HbA1c)</title>
        <description>Glycated hemoglobin (HbA1c) expressed as a percentage of hemoglobin molecules bound to glucose.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Glycated Hemoglobin (HbA1c)</title>
          <description>Glycated hemoglobin (HbA1c) expressed as a percentage of hemoglobin molecules bound to glucose.</description>
          <units>percentage of hemoglobin molecules</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.84" spread="0.95"/>
                    <measurement group_id="O2" value="9.03" spread="1.07"/>
                    <measurement group_id="O3" value="9.24" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.14" spread="1.38"/>
                    <measurement group_id="O2" value="9.06" spread="1.10"/>
                    <measurement group_id="O3" value="8.96" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.95" spread="1.14"/>
                    <measurement group_id="O2" value="9.35" spread="1.30"/>
                    <measurement group_id="O3" value="9.09" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.96" spread="1.04"/>
                    <measurement group_id="O2" value="9.51" spread="1.37"/>
                    <measurement group_id="O3" value="9.05" spread="1.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.86</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-.003</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.2</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.43</ci_lower_limit>
            <ci_upper_limit>0.36</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.41</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.19</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.78</ci_lower_limit>
            <ci_upper_limit>-0.04</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Technology Questionnaire-Adolescents</title>
        <description>Adolescent's total score on the DTQ-Current items. Range 30-150. Higher scores indicate more favorable satisfaction with and impact of the package of diabetes technology (e.g. pump, meter, CGM, etc.) in use by the patient during the prior 3 months.</description>
        <time_frame>Baseline, 3 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Technology Questionnaire-Adolescents</title>
          <description>Adolescent's total score on the DTQ-Current items. Range 30-150. Higher scores indicate more favorable satisfaction with and impact of the package of diabetes technology (e.g. pump, meter, CGM, etc.) in use by the patient during the prior 3 months.</description>
          <units>Total score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.50" spread="18.29"/>
                    <measurement group_id="O2" value="101.73" spread="23.26"/>
                    <measurement group_id="O3" value="105.16" spread="27.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.24" spread="24.44"/>
                    <measurement group_id="O2" value="92.50" spread="20.28"/>
                    <measurement group_id="O3" value="105.95" spread="27.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109.32" spread="19.57"/>
                    <measurement group_id="O2" value="107.51" spread="21.65"/>
                    <measurement group_id="O3" value="113.19" spread="24.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112.62" spread="23.69"/>
                    <measurement group_id="O2" value="103.00" spread="21.95"/>
                    <measurement group_id="O3" value="103.93" spread="27.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-10.05</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.72</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-19.30</ci_lower_limit>
            <ci_upper_limit>-0.81</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.88</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.82</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.47</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.54</ci_lower_limit>
            <ci_upper_limit>9.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Technology Questionnaire-Parents' Total Scores on DTQ Current Items</title>
        <description>Parents' ratings of impact and satisfaction with the diabetes devices currently in use (e.g. pump, meter, CGM etc.) Score range from 30-150. Higher score signify greater satisfaction and impact.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Technology Questionnaire-Parents' Total Scores on DTQ Current Items</title>
          <description>Parents' ratings of impact and satisfaction with the diabetes devices currently in use (e.g. pump, meter, CGM etc.) Score range from 30-150. Higher score signify greater satisfaction and impact.</description>
          <units>Total scores</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.06" spread="17.39"/>
                    <measurement group_id="O2" value="91.68" spread="21.34"/>
                    <measurement group_id="O3" value="86.87" spread="27.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.48" spread="25.03"/>
                    <measurement group_id="O2" value="93.78" spread="21.35"/>
                    <measurement group_id="O3" value="95.92" spread="26.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.21" spread="25.82"/>
                    <measurement group_id="O2" value="94.70" spread="19.25"/>
                    <measurement group_id="O3" value="96.27" spread="29.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.65" spread="21.61"/>
                    <measurement group_id="O2" value="96.79" spread="18.15"/>
                    <measurement group_id="O3" value="98.53" spread="23.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.49</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Generalized Estimating Equation</param_type>
            <param_value>-3.45</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.98</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.21</ci_lower_limit>
            <ci_upper_limit>6.32</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.66</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>2.53</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.76</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Glucose Monitoring Communication Questionnaire-Adolescent</title>
        <description>Adolescent report of communication with parents about blood glucose monitoring and results. Range 8-24. Higher scores indicate more negative communication about BG results.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Glucose Monitoring Communication Questionnaire-Adolescent</title>
          <description>Adolescent report of communication with parents about blood glucose monitoring and results. Range 8-24. Higher scores indicate more negative communication about BG results.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.24" spread="2.84"/>
                    <measurement group_id="O2" value="14.46" spread="3.04"/>
                    <measurement group_id="O3" value="14.29" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.46" spread="2.80"/>
                    <measurement group_id="O2" value="14.43" spread="3.72"/>
                    <measurement group_id="O3" value="13.54" spread="4.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.76" spread="3.88"/>
                    <measurement group_id="O2" value="14.57" spread="4.36"/>
                    <measurement group_id="O3" value="13.16" spread="4.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.25" spread="3.76"/>
                    <measurement group_id="O2" value="14.03" spread="4.49"/>
                    <measurement group_id="O3" value="14.47" spread="4.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.64</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.40</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.86</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.29</ci_lower_limit>
            <ci_upper_limit>2.08</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.65</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.41</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.92</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.22</ci_lower_limit>
            <ci_upper_limit>1.39</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Glucose Monitoring Communication Questionnaire-Parents</title>
        <description>Parents perspectives of communication with adolescent around blood glucose monitoring and results. Score range 8-24. Higher scores signify more negative communication about BG results.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Glucose Monitoring Communication Questionnaire-Parents</title>
          <description>Parents perspectives of communication with adolescent around blood glucose monitoring and results. Score range 8-24. Higher scores signify more negative communication about BG results.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.08" spread="2.83"/>
                    <measurement group_id="O2" value="14.59" spread="2.87"/>
                    <measurement group_id="O3" value="14.29" spread="3.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.46" spread="3.05"/>
                    <measurement group_id="O2" value="15.13" spread="3.29"/>
                    <measurement group_id="O3" value="12.84" spread="3.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.16" spread="3.14"/>
                    <measurement group_id="O2" value="15.41" spread="3.43"/>
                    <measurement group_id="O3" value="12.72" spread="3.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.46" spread="3.39"/>
                    <measurement group_id="O2" value="14.36" spread="1.95"/>
                    <measurement group_id="O3" value="13.69" spread="3.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.99</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.71</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>63.40</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-123.56</ci_lower_limit>
            <ci_upper_limit>124.97</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.93</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.22</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>13.81</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-28.26</ci_lower_limit>
            <ci_upper_limit>25.83</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Family Conflict Scale-Adolescent</title>
        <description>Adolescent ratings of degree of diabetes-related family conflict. Score range 19-57. Higher scores indicate more frequent family conflict around diabetes.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Family Conflict Scale-Adolescent</title>
          <description>Adolescent ratings of degree of diabetes-related family conflict. Score range 19-57. Higher scores indicate more frequent family conflict around diabetes.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.72" spread="7.25"/>
                    <measurement group_id="O2" value="27.54" spread="7.92"/>
                    <measurement group_id="O3" value="27.59" spread="8.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.41" spread="7.22"/>
                    <measurement group_id="O2" value="29.70" spread="9.57"/>
                    <measurement group_id="O3" value="25.26" spread="8.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.07" spread="9.31"/>
                    <measurement group_id="O2" value="28.73" spread="8.48"/>
                    <measurement group_id="O3" value="24.35" spread="7.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.68" spread="9.31"/>
                    <measurement group_id="O2" value="27.29" spread="6.56"/>
                    <measurement group_id="O3" value="25.06" spread="9.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.43</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.17</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.47</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.70</ci_lower_limit>
            <ci_upper_limit>4.04</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.08</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-2.59</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.87</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.50</ci_lower_limit>
            <ci_upper_limit>0.32</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Family Conflict Scale-Parent</title>
        <description>Parents' ratings of degree of diabetes-related family conflict. Score range 19-57. Higher scores indicate more family conflict around diabetes.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Family Conflict Scale-Parent</title>
          <description>Parents' ratings of degree of diabetes-related family conflict. Score range 19-57. Higher scores indicate more family conflict around diabetes.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.76" spread="7.27"/>
                    <measurement group_id="O2" value="27.76" spread="5.12"/>
                    <measurement group_id="O3" value="27.75" spread="6.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.36" spread="8.48"/>
                    <measurement group_id="O2" value="30.29" spread="7.82"/>
                    <measurement group_id="O3" value="24.85" spread="5.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.62" spread="8.68"/>
                    <measurement group_id="O2" value="29.05" spread="8.44"/>
                    <measurement group_id="O3" value="24.85" spread="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.68" spread="5.38"/>
                    <measurement group_id="O2" value="29.43" spread="6.85"/>
                    <measurement group_id="O3" value="24.18" spread="3.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.43</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.32</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.66</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.94</ci_lower_limit>
            <ci_upper_limit>4.56</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.007</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-3.71</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.36</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.38</ci_lower_limit>
            <ci_upper_limit>-1.04</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Family Responsibility Questionnaire-Adolescent</title>
        <description>Adolescent's self-ratings of their degree of responsibility for 38 diabetes tasks. Score range 0-76. Lower scores indicate greater adolescent responsibility for diabetes care.</description>
        <time_frame>Baserline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Family Responsibility Questionnaire-Adolescent</title>
          <description>Adolescent's self-ratings of their degree of responsibility for 38 diabetes tasks. Score range 0-76. Lower scores indicate greater adolescent responsibility for diabetes care.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.53" spread="4.74"/>
                    <measurement group_id="O2" value="31.15" spread="5.04"/>
                    <measurement group_id="O3" value="31.38" spread="5.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.20" spread="5.36"/>
                    <measurement group_id="O2" value="31.56" spread="4.15"/>
                    <measurement group_id="O3" value="30.48" spread="5.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.85" spread="4.88"/>
                    <measurement group_id="O2" value="29.96" spread="4.15"/>
                    <measurement group_id="O3" value="28.71" spread="5.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.65" spread="4.72"/>
                    <measurement group_id="O2" value="30.25" spread="4.16"/>
                    <measurement group_id="O3" value="29.56" spread="5.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.75</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.39</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.23</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.02</ci_lower_limit>
            <ci_upper_limit>2.79</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.39</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.38</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.09</ci_lower_limit>
            <ci_upper_limit>2.32</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Family Responsibility Questionnaire-Parent</title>
        <description>Parent ratings of adolescent's degree of responsibility for 38 diabetes tasks. Score range 0-76. Lower scores indicate great adolescent responsibility for diabetes care tasks.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Family Responsibility Questionnaire-Parent</title>
          <description>Parent ratings of adolescent's degree of responsibility for 38 diabetes tasks. Score range 0-76. Lower scores indicate great adolescent responsibility for diabetes care tasks.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.44" spread="4.05"/>
                    <measurement group_id="O2" value="35.19" spread="5.22"/>
                    <measurement group_id="O3" value="33.97" spread="5.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.22" spread="5.31"/>
                    <measurement group_id="O2" value="34.23" spread="6.32"/>
                    <measurement group_id="O3" value="33.62" spread="4.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.50" spread="4.19"/>
                    <measurement group_id="O2" value="34.35" spread="6.47"/>
                    <measurement group_id="O3" value="32.30" spread="5.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.00" spread="4.01"/>
                    <measurement group_id="O2" value="35.10" spread="5.15"/>
                    <measurement group_id="O3" value="33.28" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.58</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.72</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.31</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.86</ci_lower_limit>
            <ci_upper_limit>3.29</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.93</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>1.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.17</ci_lower_limit>
            <ci_upper_limit>1.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Self Management Profile-Adolescent</title>
        <description>Adolescent self-report of diabetes management behaviors. Score range 0-86. Higher scores indicate more meticulous diabetes treatment adherence.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Self Management Profile-Adolescent</title>
          <description>Adolescent self-report of diabetes management behaviors. Score range 0-86. Higher scores indicate more meticulous diabetes treatment adherence.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.05" spread="14.71"/>
                    <measurement group_id="O2" value="60.25" spread="13.68"/>
                    <measurement group_id="O3" value="59.38" spread="12.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.82" spread="13.88"/>
                    <measurement group_id="O2" value="58.73" spread="14.19"/>
                    <measurement group_id="O3" value="57.79" spread="13.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.36" spread="14.03"/>
                    <measurement group_id="O2" value="61.14" spread="13.22"/>
                    <measurement group_id="O3" value="59.07" spread="13.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.43" spread="14.49"/>
                    <measurement group_id="O2" value="58.74" spread="13.74"/>
                    <measurement group_id="O3" value="58.13" spread="14.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.46</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>1.95</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.66</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.26</ci_lower_limit>
            <ci_upper_limit>7.15</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.24</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-3.01</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.54</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.99</ci_lower_limit>
            <ci_upper_limit>1.96</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Self Management Profile-Parent</title>
        <description>Parent report of adolescent's diabetes self-management behaviors. Score range 0-86. Higher scores indicate more meticulous diabetes treatment adherence.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Self Management Profile-Parent</title>
          <description>Parent report of adolescent's diabetes self-management behaviors. Score range 0-86. Higher scores indicate more meticulous diabetes treatment adherence.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.76" spread="13.81"/>
                    <measurement group_id="O2" value="55.45" spread="14.06"/>
                    <measurement group_id="O3" value="55.94" spread="13.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.15" spread="13.49"/>
                    <measurement group_id="O2" value="58.18" spread="14.51"/>
                    <measurement group_id="O3" value="59.07" spread="12.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.93" spread="14.17"/>
                    <measurement group_id="O2" value="59.26" spread="14.37"/>
                    <measurement group_id="O3" value="60.19" spread="14.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.38" spread="13.65"/>
                    <measurement group_id="O2" value="57.16" spread="13.58"/>
                    <measurement group_id="O3" value="58.73" spread="14.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.93</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.31</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.37</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.33</ci_lower_limit>
            <ci_upper_limit>6.91</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.45</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-2.21</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.95</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.01</ci_lower_limit>
            <ci_upper_limit>3.57</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hypoglycemia Fear Survey-Adolescent</title>
        <description>Adolescent worry and behavior related to apprehension of low BG episodes. Score range 24-72. Higher scores indicate greater fear and avoidance of hypoglycemia</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Hypoglycemia Fear Survey-Adolescent</title>
          <description>Adolescent worry and behavior related to apprehension of low BG episodes. Score range 24-72. Higher scores indicate greater fear and avoidance of hypoglycemia</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.94" spread="11.69"/>
                    <measurement group_id="O2" value="35.8" spread="12.46"/>
                    <measurement group_id="O3" value="35.39" spread="12.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.95" spread="12.86"/>
                    <measurement group_id="O2" value="37.15" spread="15.34"/>
                    <measurement group_id="O3" value="31.00" spread="12.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.01" spread="12.98"/>
                    <measurement group_id="O2" value="35.30" spread="11.55"/>
                    <measurement group_id="O3" value="32.19" spread="16.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.91" spread="9.31"/>
                    <measurement group_id="O2" value="38.00" spread="15.38"/>
                    <measurement group_id="O3" value="35.24" spread="14.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.81</p_value>
            <method>Generalized Estimating Equestion</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-0.77</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>3.26</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.15</ci_lower_limit>
            <ci_upper_limit>5.62</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.72</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.99</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.63</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.11</ci_lower_limit>
            <ci_upper_limit>6.08</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hypoglycemia Fear Survey-Parent</title>
        <description>Parental worry and behavior related to apprehension of low BG events. Score range 24-72. Higher scores indicate greater parental fear and avoidance of hypoglycemia.</description>
        <time_frame>Baseline, 3, 6, 9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Glucose Sensor</title>
            <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
          </group>
          <group group_id="O3">
            <title>CGS + Behavior Therapy</title>
            <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
          </group>
        </group_list>
        <measure>
          <title>Hypoglycemia Fear Survey-Parent</title>
          <description>Parental worry and behavior related to apprehension of low BG events. Score range 24-72. Higher scores indicate greater parental fear and avoidance of hypoglycemia.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.31" spread="15.2"/>
                    <measurement group_id="O2" value="43.5" spread="11.52"/>
                    <measurement group_id="O3" value="44.09" spread="13.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.07" spread="12.00"/>
                    <measurement group_id="O2" value="41.56" spread="10.72"/>
                    <measurement group_id="O3" value="39.79" spread="9.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.59" spread="12.70"/>
                    <measurement group_id="O2" value="43.14" spread="9.49"/>
                    <measurement group_id="O3" value="41.76" spread="16.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.48" spread="11.62"/>
                    <measurement group_id="O2" value="39.87" spread="7.48"/>
                    <measurement group_id="O3" value="40.67" spread="11.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.71</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.99</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.11</ci_lower_limit>
            <ci_upper_limit>6.08</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>Generalized Estimating Equation</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.16</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.85</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.74</ci_lower_limit>
            <ci_upper_limit>4.43</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>9 months for each participant</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Care</title>
          <description>Standard Care constitutes intensified diabetes management, an enrollment criterion for the study, consisting of either continuous subcutaneous insulin infusion (insulin pump) or multiple daily injections using a &quot;basal-bolus&quot; approach. All patients must be using carbohydrate counting and have prescribed correction factors for targeted insulin bolus dose adjustments.
Standard Care: Intensified diabetes management based on either insulin pump or multiple daily injection insulin regimen, employing carbohydrate counting and a bolus dose correction factor for adjusting insulin doses.</description>
        </group>
        <group group_id="E2">
          <title>Continuous Glucose Sensor</title>
          <description>Patients will have the same diabetes management regimen as those in the Standard Care group. In addition they will be given a continuous glucose sensor, receive expert instruction in its use, and be guided by a physician and diabetes educator in achieving glycemic benefits through retrospective and real-time interpretation of CGS results and by learning to respond judiciously to the various CGS alarms.
Continuous Glucose Sensor: Education and medical management to promote optimal therapeutic benefit from adding use of a continuous glucose sensor to daily diabetes management.</description>
        </group>
        <group group_id="E3">
          <title>CGS + Behavior Therapy</title>
          <description>Patients in the use group will receive the same medical management as the Continuous Glucose Sensor group above. In addition, they will have 6 scheduled encounters with a behavior therapist that are designed to reduce or eliminate typical behavioral and/or psychological barriers to optimal use of CGS as part of diabetes care.
CGS + Behavior Therapy: Patients in this group will receive 6 scheduled encounters with a behavior therapist who will assist the adolescent and parent in reducing or eliminating common behavioral and psychological barriers to achieving optimal benefit from CGS use in diabetes care.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="35"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tim Wysocki, PhD</name_or_title>
      <organization>Nemours Foundation: Dept. of Biomedical Research</organization>
      <phone>904-697-3483</phone>
      <email>twysocki@nemours.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

